Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Fuji
McKesson
Baxter
Healthtrust
QuintilesIMS
Cerilliant
Colorcon
McKinsey

Generated: August 18, 2017

DrugPatentWatch Database Preview

AMOXICILLIN AND CLAVULANATE POTASSIUM Drug Profile

« Back to Dashboard

Which patents cover Amoxicillin And Clavulanate Potassium, and what generic Amoxicillin And Clavulanate Potassium alternatives are available?

Amoxicillin And Clavulanate Potassium is a drug marketed by Teva, Sun Pharm Inds Ltd, Micro Labs Ltd India, Apotex Inc, Sandoz Inc, Wockhardt Eu Operatn, Hikma Pharms, Sandoz, Wockhardt, Aurobindo Pharma Ltd, and Teva Pharms Usa. and is included in thirty-three NDAs.

The generic ingredient in AMOXICILLIN AND CLAVULANATE POTASSIUM is amoxicillin; clavulanate potassium. There are forty-four drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.

Summary for Tradename: AMOXICILLIN AND CLAVULANATE POTASSIUM

Patents:0
Applicants:11
NDAs:33
Suppliers / Packagers: see list42
Bulk Api Vendors: see list2
Clinical Trials: see list105,541
Patent Applications: see list160
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AMOXICILLIN AND CLAVULANATE POTASSIUM at DailyMed

Pharmacology for Tradename: AMOXICILLIN AND CLAVULANATE POTASSIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms
AMOXICILLIN AND CLAVULANATE POTASSIUM
amoxicillin; clavulanate potassium
FOR SUSPENSION;ORAL065191-001Jan 25, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
AMOXICILLIN AND CLAVULANATE POTASSIUM
amoxicillin; clavulanate potassium
TABLET;ORAL091569-002Jan 20, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz Inc
AMOXICILLIN AND CLAVULANATE POTASSIUM
amoxicillin; clavulanate potassium
FOR SUSPENSION;ORAL065098-002Dec 16, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
AMOXICILLIN AND CLAVULANATE POTASSIUM
amoxicillin; clavulanate potassium
FOR SUSPENSION;ORAL065066-001Jun 5, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Hikma Pharms
AMOXICILLIN AND CLAVULANATE POTASSIUM
amoxicillin; clavulanate potassium
FOR SUSPENSION;ORAL065373-001Nov 9, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Cipla
Chubb
Cantor Fitzgerald
McKesson
Accenture
Covington
Boehringer Ingelheim
US Department of Justice
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot